Canada explains updates to guideline on mandatory reporting of device problems
This article was originally published in SRA
Health Canada has issued a statement summarising the recent changes it has made to its guideline on mandatory reporting of medical device problems and a related reporting form1-3.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.